CPAT Members’ Op-ed: ACA Replacement Must Include Affordable Insurance for Preexisting Conditions
NCCS' Cancer Policy & Advocacy Team (CPAT) members Jen Campisano and Ben Fishman wrote a powerful op-ed for STAT News. Both diagnosed with cancer in their early thirties, they each have endured well over a million dollars in surgeries, radiation, and chemotherapy to treat their illness. Without the preexisting conditions ...
So Many Reasons to Save the Affordable Care Act
For six years now, the Affordable Care Act (ACA) continues to successfully improve health care in America. It provided coverage to 20 million people, allowed young adults to stay on their parents’ insurance until 26, emphasized preventative care, and sought to address inequalities in care, especially for women. For cancer ...
NCCS Comments on CMS’s Proposed Revisions to the 2017 Physician Fee Schedule
NCCS submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed revisions to the 2017 Physician Fee Schedule. Our comments noted our support for the Oncology Care Model, but acknowledged that only a minority of cancer care providers and cancer patients will be part of this ...
NCCS Comments on Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Proposed Rule
NCCS submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed rule on the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Our comments focus on the role of consumers in identification, development, and endorsement of quality measures. As health care delivery and payment transition ...
NCCS Joins Patient Advocates in Proposing Alternative Approach to CMS’ Part B Drug Payment Demonstration
NCCS joined with patient advocacy organizations in the Cancer Leadership Council (CLC) in submitting comments to the Centers for Medicare and Medicaid Services (CMS) on its proposed Part B drug payment demonstration project. Over many years, the CLC has advocated reforms in Medicare reimbursement for cancer care, to support the ...
NCCS Offers Comments on Alternative Payment Models for Cancer Care as Part of the Merit-Based Incentive Payment System (MIPS)
NCCS submitted comments to the Centers for Medicare and Medicaid Services (CMS) in response to its request for feedback on the implementation key provisions of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Specifically, we offered comments on alternative payment models for cancer care as part of the ...
WCOE: Cancer Causing Infections, the Uncertainty of Prognosis, A Grim Breast Cancer Milestone for Black Women, Important Healthcare Marketplace Dates, and the Financial Toll of Cancer
What Caught Our Eye (WCOE) Each week, we recap the cancer policy articles, studies, and stories that caught our attention. Some viruses and other infectious agents can cause cancer in infected people. Here's a list: https://t.co/SMtaEBaIor— National Cancer Institute (@theNCI) October 28, 2015 The Uncertainty of Prognosis in Cancer: You ...
WCOE: Life-saving End-of-life Discussions, New HHS Investment, When Seniors Talk to Med Students, and More
What Caught Our Eye (WCOE) Each week, we recap the cancer policy articles, studies, and stories that caught our attention. "A nurse with fatal breast cancer says end-of-life discussions saved her life" #choosingwisely @NotesOnNursing https://t.co/cPhjYxPKGt— ABIM Foundation (@ABIMFoundation) September 29, 2015 How does cancer affect people from different populations and ...
NCCS Submits Letters, Joins Cancer Leadership Council and C-P Alliance, in Comments to CMS on Proposed Revisions to Medicare Physician Fee Schedule
NCCS submitted letters to the Centers for Medicare and Medicaid Services (CMS) on its proposed revisions to the Medicare physician fee schedule for calendar year 2016. In our letter, NCCS commended CMS for its efforts to enhance comprehensive care management for certain Medicare beneficiaries. Through improvements in fee-for-service payments and various ...
NCCS Responds to Draft ASCO Conceptual Framework to Assess the Value of Cancer Treatment Options
NCCS recently submitted comments to the American Society for Clinical Oncology (ASCO) on its proposed value framework. In June, ASCO published a draft of the framework, "A Conceptual Framework to Assess the Value of Cancer Treatment Options," in the Journal of Clinical Oncology and solicited feedback from stakeholders. ASCO described ...
